| |
|
|
|
Xtalks, Online
2025-10-27
Although children constitute 27% of the world’s population, at least 50% of all drug products may still lack pediatric labelling. Drugs without appropriate clinical research in pediatric patients significantly increase the risk of unexpected adverse events.
However, with the evolution of pediatric legislation, the pharmaceutical industry has demonstrated a growing commitment to pediatric studies, and renewed interest in therapeutics for rare diseases has increased the demand for timely, high-quality and cost‐effective clinical trials in children.
Despite significant progress in pediatric clinical research, childhood cancer remains a leading cause of death among children. Continued research is crucial for developing new treatments that can improve survival rates and outcomes. Pediatric cancer clinical trials encounter many challenges, especially within today’s clinical drug development landscape. These include the need for targeted therapies for children, regulatory delays and design constraints, and gaps in representation and equity within current clinical trial research. Conversely, the infrastructure of cooperative groups conducting clinical trials is excellent in the US and Europe. However, offering studies in other parts of the world where the incidence of pediatric malignancies is even higher and fewer treatments are available remains a major obstacle.
This webinar addresses these key challenges in advanced therapies, including gene and cellular therapies, while offering different and innovative approaches that can be put into practice so that future clinical trials can avoid enrollment challenges and delays in study timelines. Ultimately, this results in the best chance for clinical trial success and better outcomes for patients.
Register for this webinar to learn how novel strategies are transforming pediatric clinical trials in oncology and hematology.
Keywords: Cancer, Cell & Gene Therapies, Clinical Research, Clinical Trials, CRO, Drug Development, Oncology, Patient Recruitment, Pediatric Clinical Trials, Pediatric Drug Development, Pediatric Oncology, Pediatric Patients, Pediatrics, Regulatory, Sites, Therapeutic Areas
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Charity Schuller, PharmD, MS, RAC, Executive Director, Regulatory Affairs, Head of Regulatory Intelligence and Delivery, Thermo Fisher Scientific
Mariana Burin, MD, Medical Director, Clinical Research, Thermo Fisher Scientific
Marcie Weil, MD, Medical Director, Clinical Research, Thermo Fisher Scientific
Sheree Gilmore, Project Lead, Clinical Research, Thermo Fisher Scientific
Sush Sankpal, MD, Medical Director, Clinical Research, Thermo Fisher Scientific
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-10-27
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|